ThermoGenesis (THMO) Drops 7.62% on June 22

Equities Staff  |

Today ThermoGenesis Holdings Inc (NASDAQ: THMO) is trading 7.62% lower.

The latest price, as of 11:56:17 est, was $0.32. ThermoGenesis dropped $0.0263 over the previous day’s close.

147,307 shares have traded hands.

As of the previous close, ThermoGenesis has a YTD change of 65.84%. The company anticipates its next earnings on 2022-08-11.

For technical charts, analysis, and more on ThermoGenesis visit the company profile.

About ThermoGenesis Holdings Inc

ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.

To get more information on ThermoGenesis Holdings Inc and to follow the company's latest updates, you can visit the company's profile page here: ThermoGenesis Holdings Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade

Market Movers

Sponsored Financial Content